Treatment of adult ADHD: Is current knowledge useful to clinicians?
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Psychostimulant drugs have for decades been considered the cornerstone of ADHD treatment. Non-stimulant drugs have also been reported successful. However, many controlled studies exclude patients with comorbidities typical for patients seen in clinical setting. Many patients are also considered non-responders to medication. Current knowledge might not be directly useful to clinicians. The present article reviews the literature on pharmacological and psychotherapeutic treatment in adult ADHD emphasizing comorbidity and other clinically important factors, as well as ADHD specific outcomes. Thirty-three relevant studies of pharmacotherapy and three studies of psychotherapy were included. Most subjects had little current comorbidity, but some studies included subjects with substance use disorder. Significant effect of treatment on ADHD symptoms was found in most studies using pharmacotherapy and all studies of psychotherapy. Both positive and negative effects on comorbid anxiety and depression measures were reported. Pharmacotherapy did not seem to have effect on substance use disorder. Few pharmacotherapy studies conducted any long-term follow-up; two studies that did, found that most subjects had discontinued medication. A clear-cut dose-respons relationship was not substanciated. In conclusion, clinicians have good support for both pharmacological and psychotherapeutic treatment of ADHD in adults, but should take additional measures to deal with comorbidities as well as treatment adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109 · cited 1×
“However, this fi nding is consistent with a large review of 75 placebo-controlled trials of antidepressants as treatment for major depression (Walsh et al 2002), showing a growing placebo response in studies over decades, and that in half of the studies the placebo response exceeded 30%.”
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790
Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
Murphy, K., & Barkley, R. A. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90022-x · Cited by 700 · cited 1×
“A diagnosis of ADHD has been associated with functional impairment in important life aspects like education, work and relationships (Murphy and Barkley 1996; Torgersen et al 2006).”
MTA Cooperative Group (2004) · Pediatrics · doi:10.1542/peds.113.4.754 · Cited by 589
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms
Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.001 · Cited by 519 · cited 2×
“The search revealed three randomized, controlled studies of psychotherapy in adult ADHD patients, two from Australia (Stevenson et al 2002, 2003) and one from the US (Safren et al 2005).”
SANDRA KOOIJ, J. J., BUITELAAR, J. K., van den OORD, E. J., FURER, J. W., TH. RIJNDERS, C. A., & HODIAMONT, P. P. G. (2005) · Psychological Medicine · doi:10.1017/s003329170400337x · Cited by 468 · cited 1×
“The validity of the diagnosis is now recognized (Clarke et al 2005; Kooij et al 2005) although the prevalence of the disorder and the degree of sustained symptoms as well as the presentation of symptoms in adults are disputed.”
Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108984.11879.95 · Cited by 404 · cited 2×
“Previous reviews (Wilens et al 2002; Dodson 2005) and a meta-analysis on pharmacologic treatment of adult ADHD (Faraone et al 2004) have shown robust effi cacy of stimulants on the core symptoms of ADHD in adults, and a dose-response relationship has been postulated.”
Spencer, T. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180020004 · Cited by 402 · cited 1×
“…in adults with ADHD, including one study with dexmethylphenidate (Wood et al 1976; Mattes et al 1984; Gualtieri et al 1985; Wender et al 1985; Spencer et al 1995, 2005, 2006; Kuperman et al 2001; Levin et al 2001, 2006, 2007; Schubiner et al 2002; Tenenbaum et al 2002; Bouffard et al 2003;…”
Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385 · cited 1×
“…in adults with ADHD, including one study with dexmethylphenidate (Wood et al 1976; Mattes et al 1984; Gualtieri et al 1985; Wender et al 1985; Spencer et al 1995, 2005, 2006; Kuperman et al 2001; Levin et al 2001, 2006, 2007; Schubiner et al 2002; Tenenbaum et al 2002; Bouffard et al 2003;…”
Hesslinger, B., Tebartz van Elst, L., Nyberg, E., Dykierek, P., Richter, H., Berner, M., & Ebert, D. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0379-0 · Cited by 366 · cited 1×
“Two relevant open studies on psychotherapy in adult ADHD (Hesslinger et al 2002; Rostain and Ramsay 2006) support the fi ndings in the randomized controlled studies indicating effi cacy of cognitive therapy in adult ADHD.”
A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults
Wilens, T. E., Spencer, T. J., Biederman, J., Girard, K., Doyle, R., Prince, J., Polisner, D., Solhkhah, R., Comeau, S., Monuteaux, M. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.282 · Cited by 272 · cited 2×
“Four of the studies used Bupropion in doses up to 400 mg/day (Kuperman et al 2001; Wilens et al 2001, 2005; Adler et al 2006; Levin et al 2006), three studies used Atomoxetine/Tomoxetine in doses from 60–120 mg/day (Spencer et al 1998; Michelson et al 2003), and one study used Desipramine with a…”
Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., Dunkel, S., Dougherty, M., Aleardi, M., & Spencer, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.011 · Cited by 267
A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., & Stevenson, R. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01052.x · Cited by 261 · cited 4×
“The treatment period ranged from 8 to 15 weeks, and two studies had follow-up periods of 2 and 12 months, respectively (Stevenson et al 2002, 2003).”
InfluentialNutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073219 · Cited by 259 · cited 1×
“Studies suggest that up to 90% (Nutt et al 2007) of adult patients with ADHD have one or more comorbid psychiatric disorder.”
Spencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250 · cited 2×
“In the study by Spencer and colleagues (Spencer et al 2001) the percentage of subjects who improved, defi ned as a 30% reduction in the ADHD symptom rating scale, was very large compared to placebo (70% vs 7%).”
Schubiner, H., Downey, K. K., Arfken, C. L., Johanson, C.-E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.286 · Cited by 249
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1147 · Cited by 228 · cited 1×
“…up to 400 mg/day (Kuperman et al 2001; Wilens et al 2001, 2005; Adler et al 2006; Levin et al 2006), three studies used Atomoxetine/Tomoxetine in doses from 60–120 mg/day (Spencer et al 1998; Michelson et al 2003), and one study used Desipramine with a mean dose of 147 mg/day (Wilens et al 1996).”
Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220 · cited 1×
“…(Wood et al 1976; Mattes et al 1984; Gualtieri et al 1985; Wender et al 1985; Spencer et al 1995, 2005, 2006; Kuperman et al 2001; Levin et al 2001, 2006, 2007; Schubiner et al 2002; Tenenbaum et al 2002; Bouffard et al 2003; Kooij et al 2004; Carpentier et al 2005; Biederman et…”
ADHD in adults: A study of clinical characteristics, impairment and comorbidity
Torgersen, T., Gjervan, B., & Rasmussen, K. (2006) · Nordic Journal of Psychiatry · doi:10.1080/08039480500520665 · Cited by 211 · cited 1×
“A diagnosis of ADHD has been associated with functional impairment in important life aspects like education, work and relationships (Murphy and Barkley 1996; Torgersen et al 2006).”
Self-citationA Combined Treatment Approach for Adults With ADHD—Results of an Open Study of 43 Patients
Rostain, A. L., & Ramsay, J. R. (2006) · Journal of Attention Disorders · doi:10.1177/1087054706288110 · Cited by 199 · cited 1×
“Two relevant open studies on psychotherapy in adult ADHD (Hesslinger et al 2002; Rostain and Ramsay 2006) support the fi ndings in the randomized controlled studies indicating effi cacy of cognitive therapy in adult ADHD.”
Wilens, T. E., Haight, B. R., Horrigan, J. P., Hudziak, J. J., Rosenthal, N. E., Connor, D. F., Hampton, K. D., Richard, N. E., & Modell, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.027 · Cited by 193 · cited 2×
“Four of the studies used Bupropion in doses up to 400 mg/day (Kuperman et al 2001; Wilens et al 2001, 2005; Adler et al 2006; Levin et al 2006), three studies used Atomoxetine/Tomoxetine in doses from 60–120 mg/day (Spencer et al 1998; Michelson et al 2003), and one study used Desipramine with a…”
Taylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189 · cited 1×
“The literature search revealed six randomized, placebo-controlled trials with amphetamines in adults with ADHD (Paterson et al 1999; Taylor and Russo 2000; Spencer et al 2001; Taylor and Russo 2001; Weisler et al 2006; Weiss and Hechtman 2006).”
Reimherr, F. W., Williams, E. D., Strong, R. E., Mestas, R., Soni, P., & Marchant, B. K. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0113 · Cited by 180
KOOIJ, J. J. S., BURGER, H., BOONSTRA, A. M., VAN DER LINDEN, P. D., KALMA, L. E., & BUITELAAR, J. K. (2004) · Psychological Medicine · doi:10.1017/s0033291703001776 · Cited by 163 · cited 4×
“Actually there are indications for a negative impact on outcome measures of anxiety and depression (Tenenbaum et al 2002; Michelson et al 2003; Kooij et al 2004).”
InfluentialWeisler, R. H., Biederman, J., Spencer, T. J., Wilens, T. E., Faraone, S. V., Chrisman, A. K., Read, S. C., & Tulloch, S. J. (2006) · CNS Spectrums · doi:10.1017/s1092852900013687 · Cited by 158 · cited 3×
“In one large study of four weeks duration (Weisler et al 2006) the drop-out rate was 28%, while in a study by Weiss and colleagues (Weiss and Hechtman 2006) of 20 weeks duration the drop-out rate in the treatment group was 40%.”
Perwien, A. R., Hall, J., Swensen, A., & Swindle, R. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.2.122 · Cited by 136 · cited 1×
“Evidence from pharmacy claim records also shows that adherence to prescriptions for ADHD treatment may be low (Perwien et al 2004).”
Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults
Kuperman, S., Perry, P., Gaffney, G., Lund, B., Bever-Stille, K., Arndt, S., Holman, T., Moser, D., & Paulsen, J. (2001) · Annals of Clinical Psychiatry · doi:10.3109/10401230109148958 · Cited by 113
Asherson, P., Chen, W., Craddock, B., & Taylor, E. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.026484 · Cited by 105
Dodson, W. W. (2005) · Journal of Clinical Psychology · doi:10.1002/jclp.20122 · Cited by 88
Bouffard, R., Hechtman, L., Minde, K., & Iaboni-Kassab, F. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800806 · Cited by 81
Cited by
Hirvikoski, T., Waaler, E., Alfredsson, J., Pihlgren, C., Holmström, A., Johnson, A., Rück, J., Wiwe, C., Bothén, P., & Nordström, A.-L. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.01.001 · Cited by 182
Fredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.016 · Cited by 173
Distinguishing comorbidity and successful management of adult ADHD
Kooij, J. J. S., Huss, M., Asherson, P., Akehurst, R., Beusterien, K., French, A., Sasané, R., & Hodgkins, P. (2012) · Journal of Attention Disorders · doi:10.1177/1087054711435361 · Cited by 172
Morgensterns, E., Alfredsson, J., & Hirvikoski, T. (2016) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0182-1 · Cited by 48
Optimal management of ADHD in older adults
Torgersen, T., Gjervan, B., Lensing, M. B., & Rasmussen, K. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s59271 · Cited by 42
Self-citation
Metadata
- Authors
- Torgersen, T.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2008-03
- Volume
- 4
- Issue
- 1
- Pages
- 177
- ISSN
- 1176-6328 (ISSN-L)
- OpenAlex
- W2036241512
- Cited by
- 48
- References
- 31
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.